Multidrug-resistant tuberculosis in an HIV-positive man in the United Kingdom

Journal of Infection

Volumn 32, Issue 2, 1996, Pages 153-154

  Kelleher, P ^a   Coakley, J ^a   Anderson, J ^a   Moore Gillon, J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; CASE REPORT; FATALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM; TUBERCULOSIS; UNITED KINGDOM;

EID: 0029925019     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(96)91498-X     Document Type: Article

References (16)

1. Fischl MA, Daikos GL, Uttamchandani RB, et al. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med 1992; 117: 184-190.
2. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalised patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1514-1521.
3. Fischl MA, Uttamchandani RB, Daikos GL, et al. An outbreak of tuberculosis caused by multiple-drug resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992; 117: 177-183.
4. Watson J. Tuberculosis in Britain today. BMJ 1993; 306: 221-222.
5. Warburton ARE, Jenkins PA, Waight PA, Watson JM. Drug resistance in initial isolates of mycobacterium tuberculosis in England and Wales 1982-1991. Communicable Disease Report 1993; 3: R175-R179.
6. Barnes PF, Barrows SA. Tuberculosis in the 1990s. Ann Intern Med 1993; 119: 400-410.
7. Lederberg J, Shope RE, Oaks SC Jr, Eds. Emerging infections: microbial threats to the health in the United States. Institute of Medicine 1992 Washington D.C.: National Academy Press.
8. Honore N, Truffot-Pernot C, Banerjee A, et al. Implications of multidrug resistance for the future of short course chemotherapy of tuberculosis: a molecular study. Lancet 1994; 344: 293-?.
9. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-1709.
10. Alland D, Karlut GE, Moss AR, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330: 1710-1716.
11. Ormerod LP, Shaw RJ, Mitchell DM. Tuberculosis in the UK, 1994: current issues and future trends. Thorax 1994; 49: 1085-1089.
12. H. Masur and the Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium Avium Complex. Recommendations on Prophylaxis and Therapy for Disseminated Mycobacterium avium Complex Disease in Patients Infected with the Human Immunodificiency Virus. N Engl J Med 1993; 329: 898-904.
13. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR. Treatment of 171 with pulmonary tuberculosis resistant to isoniazid and rifampicin. N Engl J Med 1993; 328: 527-532.
14. Sharp V, Chiliade P, Sepkowitz KA. Multi drug-resistant tuberculosis and AIDS. Lancet 1994; 343: 1431-1432.
15. Weiss SE, Slocum PC, Blais FX, King B, Nunn M, Matney BG. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179-1183.
16. Hamburg MA, Frieden TR. Tuberculosis transmission in the 1990s. N Engl J Med 1994; 330: 1750-1751.